Skip to main content

Table 2 Pre-RT blood cell data and clinical and pathological response in rectal cancer patients.

From: Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer

Bloosd Cell data

Non-CR (164)

CR(15)

p value

 

Hb

12.8 ± 2.0

13.3 ± 1.1

NS

 

WBC

6600 ± 2150

6370 ± 1510

NS

 

   % neutrophil *

64.0 ± 9.5

57.8 ± 9.4

0.030

 

   % eosinophil*

3.0 ± 2.8

2.2 ± 1.2

NS

 

   % basophil *

0.5 ± 0.5

0.6 ± 0.4

NS

 

   % monocyte *

6.8 ± 2.7

7.3 ± 3.0

NS

 

   % lymphocyte*

25.6 ± 8.5

32.1 ± 9.5

0.011

 

Platelet

27.9 ± 10.9

26.7 ± 8.4

NS

 
  1. Each value is the mean ± SD before or after preoperative radiotherapy,
  2. Data were analysed using the Wilcoxon test.
  3. *: Data for white blood cell subsets after radiotheraopy were available in 168
  4. (CR15 and non-CR153) of 179 cases.